References
- Byun BJ, Kang YK. Conformational preferences and pKa value of Selenocysteine residue. Biopolymers. 2011;95:345–353.
- Seeher S, Mahdi Y, Schweizer U. Post-transcriptional control of selenoprotein biosynthesis. Curr Protein Pept Sci. 2012;13(4):337–346.
- Berry M, Banu L, Chen Y, et al. Recognition of UGA as a selenocysteine codon in type I deiodinase requires sequences in the 3ʹ untranslated region. Nature. 1991;353:273–276.
- Walczak R, Westhof E, Carbon P, et al. A novel RNA structural motif in the selenocysteine insertion element of eukaryotic selenoprotein mRNAs. Rna. 1996;2(4):367–379.
- Copeland P, Fletcher J, Carlson B, et al. A novel RNA binding protein, SBP2, is required for the translation of mammalian selenoprotein mRNAs. Embo J. 2000;19(306–314):306–314.
- Fletcher JE, Copeland PR, Driscoll DM, et al. The selenocysteine incorporation machinery: interactions between the SECIS RNA and the SECIS-binding protein SBP2. RNA. 2001;7(10):1442–1453.
- Dumitrescu AM, Liao XH, Abdullah MS, et al. Mutations in SECISBP2 result in abnormal thyroid hormone metabolism. Nat Genet. 2005;37(11):1247–1252.
- Di Cosmo C, McLellan N, Liao XH, et al. Clinical and molecular characterization of a novel selenocysteine insertion sequence-binding protein 2 (SBP2) gene mutation (R128X). J Clin Endocrinol Metab. 2009;94(10):4003–4009.
- Azevedo MF, Barra GB, Naves LA, et al. Selenoprotein-related disease in a young girl caused by nonsense mutations in the SBP2 gene. J Clin Endocrinol Metab. 2010;95(8):4066–4071.
- Schoenmakers E, Agostini M, Mitchell C, et al. Mutations in the selenocysteine insertion sequence-binding protein 2 gene lead to a multisystem selenoprotein deficiency disorder in humans. J Clin Invest. 2010;120(12):4220–4235.
- Allamand V, Richard P, Lescure A, et al. A single homozygous point mutation in a 3ʹuntranslated region motif of selenoprotein N mRNA causes SEPN1-related myopathy. EMBO Rep. 2006;7(4):450–454.
- Tujebajeva RM, Copeland PR, Xu XM, et al. Decoding apparatus for eukaryotic selenocysteine insertion. EMBO Rep. 2000;1(2):158–163.
- Fagegaltier D, Hubert N, Yamada K, et al. Characterization of mSelB, a novel mammalian elongation factor for selenoprotein translation. Embo J. 2000;19(17):4796–4805.
- Xu X, Carlson B, Mix H, et al. Biosynthesis of selenocysteine on its tRNA in eukaryotes. PLoS Biol. 2007;5:e4.
- Chavette L, Brown BA, Driscoll DM. Ribosomal protein L30 is a component of the UGA-selenocysteine recoding machinery in eukaryotes. Nat Struct Mol Biol. 2005;12(15):408–416.
- Miniard A, Middleton L, Budiman M, et al. Nucleolin binds to a subset of selenoprotein mRNAs and regulates their expression. Nucleic Acids Res. 2010;38:4807–4820.
- Budiman ME, Bubenik J, Miniard A, et al. Eukaryotic initiation factor 4a3 is a selenium-regulated RNA -binding protein that selectively inhibits selenocysteine incorporation. Mol Cell. 2009;35:479–489.
- Howard M, Aggarwal G, Anderson A, et al. Recoding elements located adjacent to a subset of eukaryal selenocysteine-specifying UGA codons. EMBO. 2005;24(8):1596–1697.
- Howard M, Moyle M, Aggarwal G, et al. A recoding element that stimulates decoding of the UGA codons by Sec tRNA [Ser]Sec. RNA. 2007;13:912–920.
- Maiti B, Arbogast S, Allamand V, et al. A mutation in the SEPN1 SRE reduces selenocysteine incorporation and leads to SEPN1-related myopathy. Hum Mutat. 2010;30(3):411–416.
- Bubenik J, Miniard A, Driscoll DM. Alternative transcripts and 3ʹUTR elements govern the incorporation of Selenocysteine into Selenoprotein S. PLOS One. 2013;8(4):e62102.
- Walder K, Kantham L, McMillan J, et al. Tanis: a link between type 2 diabetes and inflammation? Diabetes. 2002;51:1859–1866.
- Gao Y, Feng H, Walder K, et al. Regulation of the selenoproteins SelS by glucose deprivation and endoplasmic reticulum stress- SelS is a novel glucose-regulated protein. FEBS Lett. 2004;563(1–3):185–190.
- Shchedrina V, Everley R, Zhang Y, et al. Selenoprotein K binds multiprotein complexes and is involved in the regulation of endoplasmic reticulum homeostasis. J Biol Chem. 2011;286:42937–42948.
- Curran J, Jowett JBM, Elliott K, et al. Genetic variation in selenoprotein S influences inflammatory response. Nat Genet. 2005;37(11):1234–1241.
- Hannan N, Wanyonyi S, Konstantopolous N, et al. Activation of the selenoprotein SEPS1 gene expression by pro-inflammatory cytokines in HepG2 cells. Cytokine. 2006;33(5):246–251.
- Wu J, Kaufman R. From the acute ER stress to physiological roles of the unfolded protein response. Cell Death Differ. 2006;13:374–384.
- Harding HP, Zhang Y, Ron D. Protein translation and folding are coupled by an endoplasmic-reticulum-resident kinase. Nature. 1999;397(6716):271–274.
- Raven JF, Baltzis D, Wang S, et al. PKR and PKR-like endoplasmic reticulum kinase induce the proteasome-dependent degradation of cyclin D1 via a mechanism requiring eukaryotic initiation factor 2alpha phosphorylation. J Biol Chem. 2008;283(6):3097–3108.
- Wu J, Rutkowski DT, Dubois M, et al. ATF6alpha optimizes long-term endoplasmic reticulum function to protect cells from chronic stress. Dev Cell. 2007;13(3):351–364.
- Yamamoto K, Sato T, Matsui T, et al. Transcriptional induction of mammalian ER quality control proteins is mediated by single or combined action of ATF6alpha and XBP1. Dev Cell. 2007;13(3):365–376.
- Smith MH, Ploegh HL, Weissman JS. Road to ruin: targeting proteins for degradation in the endoplasmic reticulum. Science. 2011;334(6059):1086–1090.
- Ye Y, Shibata Y, Kikkert M, et al. Recruitment of the p97 ATPase and ubiquitin ligases to the site of retrotranslocation at the endoplasmic reticulum membrane. PNAS. 2005;102(40):14132–14138.
- Lee JH, Park KJ, Jang JK, et al. Selenoprotein S-dependent Selenoprotein K Binding to p97(VCP) Protein Is essential for endoplasmic reticulum-associated degradation. J Biol Chem. 2015;290(50):29941–29952.
- Ye Y, Shibata Y, Yun C, et al. A membrane protein complex mediates retro-translocation from the ER lumen into the cytosol. Nat Genet. 2004;429:841–847.
- Kim KH, Gao Y, Walder K, et al. SEPS1 protects RAW264.7 cells from pharmacological ER stress agent-induced apoptosis. Biochem Biophys Res Commun. 2007;354:127–132.
- Fradejas NPM, Mora-Lee S, Tranque P, et al. SEPS1 gene is activated during astrocyte ischemia and shows prominent antiapoptotic effects. J Mol Neurosci. 2008;35:259–265.
- Kelly E, Greene C, Carroll T, et al. Selenoprotein S/SEPS1 modifies endoplasmic reticulum stress in Z variant alpha 1-antitrypsin deficiency. J Biol Chem. 2009;284:16891–16897.
- Zheng HTZL, Huang CJ, Hua X, et al. Selenium inhibits high glucoseand high insulin induced adhesion molecule expression in vascular endothelial cells. Arch Med Res. 2008;39:373–379.
- Zhao Y, Li H, Men LL, et al. Effects of selenoprotein S on oxidative injury in human endothelial cells. J Transl Med. 2013;11:287.
- Lee JH, Kwon JH, Jeon YH, et al. Pro178 and Pro183 of selenoprotein S are essential residues for interaction with p97(VCP) during endoplasmic reticulum-associated degradation. J Biol Chem. 2014;289(20):13758–13768.
- Christensen LC, Jensen NW, Vala A, et al. The human selenoprotein VCP-interacting membrane protein (VIMP) is non-globular and harbors reductase function in an intrinsically disordered region. J Biol Chem. 2012;287(31):26388–26399.
- Liu J, Rozovsky S. Contribution of selenocysteine to the peroxidase activity of selenoprotein S. Biochemistry. 2013;52(33):5514–5516.
- Liu J, Li F, Rozovsky S. The intrinsically disordered membrane protein selenoprotein S is a reductase in vitro. Biochemistry. 2013;52(18):3051–3061.
- Bubenik JL, Ladd AN, Gerber CA, et al. Known turnover and translation regulatory RNA-binding proteins interact with the 3ʹ UTR of SECIS-binding protein 2. RNA Biol. 2009;6(1):73–83.
- Mehta A, Rebsch C, Kinzy S, et al. Efficiency of mammalian selenocysteine incorporation. J Biol Chem. 2004;279:37852–37859.
- Sievers F, Higgins DG. Clustal Omega, accurate alignment of very large numbers of sequences. Methods Mol Biol. 2014;1079:105–116.
- Gruber AR, Lorenz R, Bernhart SH, et al. The Vienna RNA websuite. Nucleic Acids Res. 2008;36(Web Server issue):W70–4.
- Mayya VK, Duchaine TF. Ciphers and executioners: how 3ʹ-untranslated regions determine the fate of messenger RNAs. Front Genet. 2019;10:6.
- Kryukov GV, Castellano S, Novoselov SV, et al. Characterization of mammalian selenoproteomes. Science. 2003;300(5624):1439–1443.
- Fagegaltier D, Lescure A, Walczak R, et al. Structural analysis of new local features in SECIS RNA hairpins. Nucleic Acids Res. 2000;2679–2689.
- Driscoll DM, Chavatte L. Finding needles in a haystack. In silico identification of eukaryotic selenoprotein genes. EMBO Rep. 2004;5(2):140–141.
- Ray PS, Jia J, Yao P, et al. A stress-responsive RNA switch regulates VEGFA expression. Nature. 2009;457(7231):915–919.
- Turanov AA, Lobanov AV, Hatfield DL, et al. UGA codon position-dependent incorporation of selenocysteine into mammalian selenoproteins. Nucleic Acids Res. 2013;41(14):6952–6959.
- Latreche L, Jean-Jean O, Driscoll DM. L C, Novel structural determinants in human SECIS elements modulate the translational recoding of UGA as selenocysteine. Nucleic Acids Res. 2009;37:5868–5880.
- Karijolich J, Yu YT. Converting nonsense codons into sense codons by targeted pseudouridylation. Nature. 2011;474(7351):395–398.